22 Dec, 2023 09:45 AM
-- Successful Site Initiation at Princess Alexandra Hospital, Brisbane for RAD 204 (PDL-1 nanobody) therapeutic Phase 1 trial
-- Phase 1 First-In-Human study in 21 patients designed to evaluate saf...read more
08 Dec, 2023 11:45 AM
On 31 October 2023, Radiopharm Theranostics Limited (ASX:RAD) (Radiopharm or Company) announced the details of a non-renounceable entitlement offer (Entitlement Offer) to raise approximately $10 mil...read more
21 Nov, 2023 10:09 AM
Sydney, Australia – 21 November 2023 – Radiopharm Theranostics Limited (ASX:RAD), a developer of a world class platform of radiopharmaceutical products for both diagnostic and thera...read more
08 Nov, 2023 09:04 AM
Sydney, Australia – 8 November 2023 – Radiopharm Theranostics (ASX:RAD), a developer of a worldclass platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is...read more
31 Oct, 2023 09:06 AM
Key Points
-- Non-renounceable entitlement offer to raise up to approximately $10 million (before direct offer costs).
-- Offer price of $0.07 per new share, a 30.0% discount to the closing pric...read more
09 Oct, 2023 10:04 AM
Sydney, Australia – 9 October 2023 – Radiopharm Theranostics (ASX:RAD), a developer of a worldclass platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is ...read more
24 Aug, 2023 09:53 AM
SYDNEY, August 24, 2023 - Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of radiopharmaceutical products for both diagnostic and therapeutic us...read more
24 Aug, 2023 09:48 AM
Rural Funds Management Limited (RFM) today released the Rural Funds Group (ASX: RFF, the Group) Financial Statements for the year ended 30 June 2023 (FY23) as summarised below.
Financial highligh...read more
14 Aug, 2023 10:20 AM
Rural Funds Management Limited (RFM), the responsible entity of Rural Funds Group (RFF), provides an update on independent valuations arranged for the six months ended 30 June 2023 (2H23).
RFF ha...read more